Chancellor Rachel Reeves Aims for Specific Action on Household Expenses in Forthcoming Financial Plan
Treasury head Reeves has revealed she is planning "targeted action to address household expense issues" in the upcoming Budget.
Speaking to media outlets, she emphasized that lowering inflation is a shared task of both the administration and the Bank of England.
The United Kingdom's price growth is expected to be the most elevated among the Group of Seven industrialized countries this year and next.
Possible Utility Cost Measures
Reports indicate the government could take action to bring down energy bills, for instance by reducing the present 5% rate of value-added tax applied on energy.
Another possibility is to reduce some of the regulatory levies currently included in bills.
Budgetary Limitations and Expert Expectations
The government will obtain the next assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much scope there is for such actions.
The consensus from the majority of analysts is that Reeves will have to announce higher taxes or spending cuts in order to fulfill her voluntary fiscal targets.
Previously on the same day, estimates suggested there was a £22bn gap for the chancellor to resolve, which is at the lower end of expectations.
"There's a collective job between the Bank of England and the government to bear down further on some of the sources of inflation," Reeves informed the BBC in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.
Tax Commitments and Global Concerns
While a great deal of the focus has been on likely tax rises, the Treasury chief said the most recent data from the fiscal watchdog had not altered her pledge to election pledges not to raise tax levels on income tax, VAT or National Insurance.
She blamed an "uncertain global environment" with growing geopolitical and trade issues for the Budget tax moves, probably to be targeted on those "most able to pay."
Global Economic Tensions
Commenting on worries about the United Kingdom's economic relations with the Asian nation she said: "Our security interests invariably come first."
Last week's declaration by Chinese authorities to increase trade restrictions on rare earths and other materials that are key for high-technology manufacturing led American leader the US President to threaten an additional 100% import tax on imports from China, raising the prospect of an full-scale trade war between the two global powers.
The US Treasury Secretary called the Chinese decision "economic coercion" and "a international production power grab."
Questioned on accepting the US offer to participate in its battle with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and encouraged the Chinese government "to avoid restrictions and restrict access."
She said the decision was "harmful for the world economy and causes additional headwinds."
"I believe there are fields where we should challenge Chinese policies, but there are also important chances to trade with China's economy, including banking sector and other areas of the economy. We've got to achieve that balance appropriate."
The Treasury chief also affirmed she was cooperating with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."
Health Service Medicine Costs and Funding
The Chancellor also recognized that the cost the NHS spends on drugs could rise as a consequence of current negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.
Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or abandoning projects in the UK, with some attributing the insufficient payments they are receiving.
Last month, the Science Minister said the price the NHS pays for medicines would must rise to halt businesses and drug research funding departing from the United Kingdom.
Reeves told media: "It has been observed because of the cost structure, that clinical trials, new drugs have not been provided in the United Kingdom in the way that they are in other European countries."
"Our aim is to ensure that patients receiving care from the NHS are able to obtain the finest essential treatments in the world. And so we are reviewing this situation, and... seeking to obtain increased funding into Britain."